News

Both GLP-1 RAs and SGLT2is are associated with a reduced risk for Alzheimer disease and related dementias among people with type 2 diabetes.
The prevalence of autism spectrum disorder (ASD) was 32.2 per 1000 children aged 8 years across 16 sites in the United States in 2022.